-
Deadweight loss of bacterial resistance due to overtreatment.
US Centers for Disease Control and Prevention, Atlanta 30341, USA. eelbasha@cdc.gov
Widespread use of antibiotics is considered the major driving force behind the development of antibiotic resistance. The benefits of exceeding the welfare-maximizing level of antibiotic use are below the costs of resistance created by this excess quantity of antibiotics used, thereby resulting in a welfare deadweight loss. This paper uses a simple economic model to examine the theoretical and empirical aspects of the welfare loss generated by resistance and analyzes its policy implications. The annual deadweight loss associated with outpatient prescriptions for amoxicillin in the United States is estimated at US dollars 225 million. Published in 2002 by John Wiley & Sons, Ltd.
PMID: 12563660 [PubMed - indexed for MEDLINE]
-
Patient Drug Information
-
Penicillin G Potassium or Sodium Injection (Pfizerpen® )
Your doctor has ordered penicillin, an antibiotic, to help treat your infection. The drug will be either injected into a large muscle (such as your buttock or hip) or added to an intravenous fluid that will drip through ...
-
Amoxicillin (Amoxil® , Amoxil® Pediatric Drops, Trimox® , ...)
Amoxicillin is used to treat certain infections caused by bacteria, such as pneumonia; bronchitis; gonorrhea; and infections of the ears, nose, throat, urinary tract, and skin. It is also used in combination with other m...